Schedules of Controlled Substances: Temporary Placement of Brorphine in Schedule I
scheduling · Proposed Rule · Proposed amendment; notice of intent. · Published 2020-12-03 · 85 FR 78047
Document
Document number
2020-26301
Federal Register citation
85 FR 78047
Type
Proposed Rule
Action
Proposed amendment; notice of intent.
Category
scheduling
Publication date
2020-12-03
Abstract
The Acting Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3- dihydro-2H-benzo[d]imidazol-2-one (commonly known as brorphine), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle brorphine.